Search Within

Population Sciences Research Program

Formats
  1. Journal Article (7256)
  2. Meeting Abstract (3358)
  3. Book Section (337)
  4. Review (306)
  5. Editorial (270)
  6. Research Letter (122)
  7. Correspondence (117)
  8. Conference Paper (67)
  9. Guidelines (60)
  10. Miscellaneous (45)
  11. Book Whole (24)
Groups
  1. Survivorship Research (5796)
  2. Department of Medicine (5281)
  3. Epidemiology and Biostatistics (5003)
  4. Solid Tumor Oncology Division (3412)
  5. Surgery (3039)
  6. Psychiatry and Behavioral Sciences, Department of (2830)

More Groups

People
  1. Andrew Vickers (898)
  2. Kenneth Offit (792)
  3. Mark Robson (684)
  4. Steven Horwitz (671)
  5. T Peter Kingham (629)
  6. Katherine Panageas (525)

More People

Years
  1. 2025 (444)
  2. 2024 (777)
  3. 2023 (819)
  4. 2022 (829)
  5. 2021 (784)
  6. 2020 (733)

More Years

Publications
  1. Journal of Clinical Oncology (1263)
  2. Blood (414)
  3. Psycho-Oncology (345)
  4. Cancer (245)
  5. Annals of Surgical Oncology (242)
  6. Cancer Research (234)

More Publications

Publishers
  1. American Society of Clinical Oncology (1442)
  2. Springer (1137)
  3. Elsevier Inc. (1079)
  4. Elsevier Science, Inc. (831)
  5. Oxford University Press (768)
  6. Wiley Blackwell (628)

More Publishers

Results (11962)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Analysis of clinical determinants driving safety and efficacy of camidanlumab tesirine (ADCT‐301, Cami) in relapsed/refractory (R/R) classical Hodgkin lymphoma (CHL)
    Meeting Abstract

    Collins, G.; Horwitz, S.; Hamadani, M.; Samaniego, F.; Spira, A.; Caimi, P.; Davies, A.; Menne, T.; Fields, P.; Cruz, H.; more...
    Hematological Oncology (2019)

    Fulltext@MSK | Save
  • Risk of breast implant associated anaplastic large cell lymphoma (BIA‐ALCL) in a cohort of 3546 women prospectively followed after receiving textured breast implants
    Meeting Abstract

    Ghione, P.; Cordeiro, P. G.; Ni, A.; Hu, Q.; Ganesan, N.; Galasso, N.; Dogan, A.; Horwitz, S. M.
    Hematological Oncology (2019)

    Fulltext@MSK | Save
  • Duvelisib, an oral dual PI3K‐δ,γ inhibitor, efficacy and safety in patients with relapsed or refractory (RR) peripheral T‐cell lymphoma: Rationale for the phase 2 PRIMO trial
    Meeting Abstract

    Horwitz, S. M.; Foss, F. M.; Porcu, P.; Moskowitz, A.; Mehta‐Shah, N.; Jacobsen, E.; Khodadoust, M. S.; Kim, Y. H.; Weinstock, D.; Lustgarten, S.; more...
    Hematological Oncology (2019)

    Fulltext@MSK | Save
  • Immunotherapy in colorectal cancer: Rationale, challenges and potential
    Review

    Ganesh, K.; Stadler, Z. K.; Cercek, A.; Mendelsohn, R. B.; Shia, J.; Segal, N. H.; Diaz, L. A. Jr
    Nature Reviews Gastroenterology & Hepatology (2019)

    Fulltext@MSK | Save
  • Towards controlled terminology for reporting germline cancer susceptibility variants: An ENIGMA report
    Guidelines

    Spurdle, A. B.; Greville-Heygate, S.; Antoniou, A. C.; Brown, M.; Burke, L.; de la Hoya, M.; Domchek, S.; Dörk, T.; Firth, H. V.; Monteiro, A. N.; more...
    Journal of Medical Genetics (2019)

    Fulltext@MSK | Save
  • Cardio-oncology rehabilitation to manage cardiovascular outcomes in cancer patients and survivors: A scientific statement from the American Heart Association
    Guidelines

    Gilchrist, S. C.; Barac, A.; Ades, P. A.; Alfano, C. M.; Franklin, B. A.; Jones, L. W.; La Gerche, A.; Ligibel, J. A.; Lopez, G.; Madan, K.; more...
    Circulation (2019)

    Fulltext@MSK | Save
  • Prospective evaluation of the cardiac safety of HER2-targeted therapies in patients with HER2-positive breast cancer and compromised heart function: The SAFE-HEaRt study
    Journal Article

    Lynce, F.; Barac, A.; Geng, X.; Dang, C.; Yu, A. F.; Smith, K. L.; Gallagher, C.; Pohlmann, P. R.; Nunes, R.; Herbolsheimer, P.; more...
    Breast Cancer Research and Treatment (2019)

    Fulltext@MSK | Save
  • Ultra-deep next-generation sequencing of plasma cell-free DNA in patients with advanced lung cancers: Results from the Actionable Genome Consortium
    Journal Article

    Li, B. T.; Janku, F.; Jung, B.; Hou, C.; Madwani, K.; Alden, R.; Razavi, P.; Reis-Filho, J. S.; Shen, R.; Isbell, J. M.; more...
    Annals of Oncology (2019)

    Fulltext@MSK | Save
  • An open trial of meaning-centered grief therapy: Rationale and preliminary evaluation
    Journal Article

    Lichtenthal, W. G.; Catarozoli, C.; Masterson, M.; Slivjak, E.; Schofield, E.; Roberts, K. E.; Neimeyer, R. A.; Wiener, L.; Prigerson, H. G.; Kissane, D. W.; more...
    Palliative and Supportive Care (2019)

    Fulltext@MSK | Save
  • Going to extremes: Determinants of extraordinary response and survival in patients with cancer
    Review

    Saner, F. A. M.; Herschtal, A.; Nelson, B. H.; deFazio, A.; Goode, E. L.; Ramus, S. J.; Pandey, A.; Beach, J. A.; Fereday, S.; Berchuck, A.; more...
    Nature Reviews Cancer (2019)

    Fulltext@MSK | Save